{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:28:14Z","timestamp":1781900894881,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T00:00:00Z","timestamp":1389398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10157-013-0891-8","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:46:36Z","timestamp":1389303996000},"page":"185-188","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiology of dyslipidemia in chronic kidney disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Kunitoshi","family":"Iseki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,11]]},"reference":[{"key":"891_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","volume":"157","author":"A Upadhyay","year":"2012","unstructured":"Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157:251\u201362.","journal-title":"Ann Intern Med"},{"key":"891_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","volume":"157","author":"SC Palmer","year":"2012","unstructured":"Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157:263\u201375.","journal-title":"Ann Intern Med"},{"key":"891_CR3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10157-011-0551-9","volume":"16","author":"K Iseki","year":"2012","unstructured":"Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on eGFR and dipstick proteinuria: analysis of the participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16:244\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"891_CR4","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1523-1755.2002.00626.x","volume":"62","author":"M Tozawa","year":"2002","unstructured":"Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol, levels predicts development of proteinuria. Kidney Int. 2002;62:1743\u20139.","journal-title":"Kidney Int"},{"key":"891_CR5","first-page":"155","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:155\u201366.","journal-title":"Kidney Int"},{"key":"891_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2006.06.003","volume":"48","author":"T Ninomiya","year":"2006","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383\u201391.","journal-title":"Am J Kidney Dis"},{"key":"891_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1291\/hypres.30.937","volume":"30","author":"M Tozawa","year":"2007","unstructured":"Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res. 2007;30:937\u201343.","journal-title":"Hypertens Res"},{"key":"891_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ki.5000050","volume":"69","author":"H Tanaka","year":"2006","unstructured":"Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369\u201374.","journal-title":"Kidney Int"},{"key":"891_CR9","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","volume":"65","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870\u20136.","journal-title":"Kidney Int"},{"key":"891_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10157-004-0332-9","volume":"9","author":"K Iseki","year":"2005","unstructured":"Iseki K, Tozawa M, Ikemiya Y, Kinjo K, Iseki C, Takishita S. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort. Clin Exp Nephrol. 2005;9:46\u201352.","journal-title":"Clin Exp Nephrol"},{"key":"891_CR11","unstructured":"Japanese Society for Dialysis Therapy. www.jsdt.or.jp . Accessed 1 Sept 2013."},{"issue":"Suppl 2","key":"891_CR12","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1097\/01.ASN.0000070153.91733.09","volume":"14","author":"K Iseki","year":"2003","unstructured":"Iseki K. The Okinawa screening program. J Am Soc Nephrol. 2003;14(Suppl 2):S127\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"891_CR13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10157-013-0776-x","volume":"17","author":"K Iseki","year":"2013","unstructured":"Iseki K. Invited review. Nephrology for the People: presidential address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012. Clin Exp Nephrol. 2013;17:480\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"891_CR14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","volume":"59","author":"L Li","year":"2012","unstructured":"Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59:504\u201312.","journal-title":"Am J Kidney Dis"},{"key":"891_CR15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468\u201374.","journal-title":"Kidney Int"},{"key":"891_CR16","first-page":"941","volume":"185","author":"T Turin","year":"2012","unstructured":"Turin T, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James M, et al. Lifetime risk of ESRD. J Am Soc Nephrol. 2012;185:941\u20132.","journal-title":"J Am Soc Nephrol"},{"key":"891_CR17","doi-asserted-by":"crossref","unstructured":"Iseki K. Chronic kidney disease: Proteinuria as a predictor of rapid eGFR decline. Nat Rev Nephrol 2013; 9:570-571 .","DOI":"10.1038\/nrneph.2013.177"},{"key":"891_CR18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2337\/diacare.26.5.1402","volume":"26","author":"GB Appel","year":"2003","unstructured":"Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, et al. Analysis of metabolic parameters as predictors of risk in the RENAAL study. Diabetes Care. 2003;26:1402\u20137.","journal-title":"Diabetes Care"},{"key":"891_CR19","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181\u201392.","journal-title":"Lancet"},{"key":"891_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, M\u00e4rz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238\u201348.","journal-title":"N Engl J Med"},{"key":"891_CR21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstr\u00f6m","year":"2009","unstructured":"Fellstr\u00f6m BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395\u2013407.","journal-title":"N Engl J Med"},{"key":"891_CR22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","volume":"63","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793\u2013808.","journal-title":"Kidney Int"},{"key":"891_CR23","unstructured":"Japanese Society of Nephrology. www.jsn.or.jp . Accessed 1 Sept 2013."},{"key":"891_CR24","doi-asserted-by":"crossref","first-page":"f880","DOI":"10.1136\/bmj.f880","volume":"346","author":"CR Dormuth","year":"2013","unstructured":"Canadian network for observational drug effect studies, Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ. 2013;346:f880. doi: 10.1136\/bmj.f880 .","journal-title":"BMJ"},{"key":"891_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10157-012-0676-5","volume":"17","author":"K Ueshima","year":"2013","unstructured":"Ueshima K, Kasahara M, Koya D, Babazono T, Sato T, Imamoto M, et al. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial. Clin Exp Nephrol. 2013;17:211\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"891_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","volume":"50","author":"DE Weiner","year":"2007","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"891_CR27","doi-asserted-by":"crossref","first-page":"e55643","DOI":"10.1371\/journal.pone.0055643","volume":"8","author":"S-C Chen","year":"2013","unstructured":"Chen S-C, Hung C\u2013C, Kuo M-C, Lee J\u2013J, Chiu Y-W, Chang J-M, et al. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One. 2013;8:e55643.","journal-title":"PLoS One"},{"key":"891_CR28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrneph.2013.104","volume":"9","author":"J Vivek","year":"2013","unstructured":"Vivek J. The price of a QALY\u2014cost-effectiveness of statins in CKD. Nat Rev Nephrol. 2013;9:377\u20139.","journal-title":"Nat Rev Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0891-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0891-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:44:39Z","timestamp":1559112279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0891-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0891-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,11]]}}}